JP2003532626A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003532626A5 JP2003532626A5 JP2001517507A JP2001517507A JP2003532626A5 JP 2003532626 A5 JP2003532626 A5 JP 2003532626A5 JP 2001517507 A JP2001517507 A JP 2001517507A JP 2001517507 A JP2001517507 A JP 2001517507A JP 2003532626 A5 JP2003532626 A5 JP 2003532626A5
- Authority
- JP
- Japan
- Prior art keywords
- embedded image
- disease
- pharmaceutical composition
- composition according
- represented
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 C*(*)S(NC)(=O)=O Chemical compound C*(*)S(NC)(=O)=O 0.000 description 2
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37823499A | 1999-08-19 | 1999-08-19 | |
| US09/378,234 | 1999-08-19 | ||
| US09/642,557 US7119114B1 (en) | 1999-08-19 | 2000-08-18 | Pyrazoloanthrone and derivatives thereof as JNK inhibitors and compositions and methods related thereto |
| US09/642,557 | 2000-08-18 | ||
| PCT/US2000/022727 WO2001012609A1 (en) | 1999-08-19 | 2000-08-19 | Pyrazoloanthrone and derivatives thereof as jnk inhibitors and their compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003532626A JP2003532626A (ja) | 2003-11-05 |
| JP2003532626A5 true JP2003532626A5 (cg-RX-API-DMAC7.html) | 2007-05-24 |
Family
ID=23492297
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001517507A Pending JP2003532626A (ja) | 1999-08-19 | 2000-08-19 | Jnk阻害剤としてのピラゾロアントロン及びその誘導体並びにそれらの組成物 |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1218347A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2003532626A (cg-RX-API-DMAC7.html) |
| KR (2) | KR20080028516A (cg-RX-API-DMAC7.html) |
| CN (1) | CN1304375C (cg-RX-API-DMAC7.html) |
| AU (1) | AU780306B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2383268A1 (cg-RX-API-DMAC7.html) |
| HK (1) | HK1053107A1 (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ517578A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2001012609A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA200201312B (cg-RX-API-DMAC7.html) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7119114B1 (en) | 1999-08-19 | 2006-10-10 | Signal Pharmaceuticals, Llc | Pyrazoloanthrone and derivatives thereof as JNK inhibitors and compositions and methods related thereto |
| US20040072888A1 (en) * | 1999-08-19 | 2004-04-15 | Bennett Brydon L. | Methods for treating inflammatory conditions or inhibiting JNK |
| US7429599B2 (en) | 2000-12-06 | 2008-09-30 | Signal Pharmaceuticals, Llc | Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK |
| GB0108770D0 (en) | 2001-04-06 | 2001-05-30 | Eisai London Res Lab Ltd | Inhibitors |
| WO2002083648A1 (fr) | 2001-04-16 | 2002-10-24 | Eisai Co., Ltd. | Nouveau compose a base de 1h-indazole |
| US7018999B2 (en) | 2001-05-16 | 2006-03-28 | Cephalon, Inc. | Methods for the treatment and prevention of pain |
| WO2003010164A1 (en) | 2001-07-23 | 2003-02-06 | Applied Research Systems Ars Holding N.V. | Arylsulfonamide derivatives as c-jun-n-terminal kinases (jnk's) inhibitors |
| US7390797B2 (en) | 2002-02-28 | 2008-06-24 | Eisai Co., Ltd. | Fused indazole compounds |
| NZ535349A (en) | 2002-03-08 | 2007-01-26 | Signal Pharm Inc | JNK inhibitors with chemotherapeutic agents in a combination therapy for treating or preventing cancer and other proliferative disorders in refractory patients in particular |
| KR20040111445A (ko) | 2002-03-28 | 2004-12-31 | 에자이 가부시키가이샤 | 신경퇴행성 질환 치료용 c─Jun N─말단 키나아제억제제로서의 7─아자인돌 |
| EP1490365B1 (en) | 2002-03-28 | 2010-02-10 | Eisai R&D Management Co., Ltd. | Azaindoles as inhibitors of c-jun n-terminal kinases |
| KR20040101398A (ko) * | 2002-04-05 | 2004-12-02 | 베링거 잉겔하임 파르마 게엠베하 운트 코 카게 | 점액 과다분비의 치료방법 |
| MXPA04011851A (es) * | 2002-05-30 | 2005-03-31 | Celgene Corp | Metodos para utilizar inhibidores de jnk o mkk para modular diferenciacion de celula y para tratar desordenes mieloproliferativos y sindromes mielodispl??sticos. |
| CN1656079A (zh) | 2002-05-31 | 2005-08-17 | 卫材株式会社 | 吡唑化合物和含有该化合物的药物组合物 |
| US20040087642A1 (en) * | 2002-10-24 | 2004-05-06 | Zeldis Jerome B. | Methods of using and compositions comprising a JNK inhibitor for the treatment, prevention, management and/or modification of pain |
| US20040092568A1 (en) * | 2002-10-31 | 2004-05-13 | Zeldis Jerome B. | Methods for the treatment, prevention and management of macular degeneration |
| US20050019366A1 (en) * | 2002-12-31 | 2005-01-27 | Zeldis Jerome B. | Drug-coated stents and methods of use therefor |
| GB0305142D0 (en) | 2003-03-06 | 2003-04-09 | Eisai London Res Lab Ltd | Synthesis |
| US7612086B2 (en) | 2003-05-16 | 2009-11-03 | Eisai R & D Management Co. Ltd. | JNK inhibitors |
| EP1684690A4 (en) * | 2003-11-06 | 2008-10-15 | Celgene Corp | METHODS OF USE AND COMPOSITIONS COMPRISING A JNK INHIBITOR FOR THE TREATMENT AND MANAGEMENT OF ASBESTOS-RELATED DISEASES AND DISORDERS |
| WO2005074921A1 (en) * | 2004-02-09 | 2005-08-18 | University Of Zurich | Treatment of atherosclerosis |
| MX2007001155A (es) * | 2004-07-29 | 2007-08-14 | Creabilis Therapeutics Spa | Uso de inhibidores de k-252a y de quinasa para la prevencion o el tratamiento de patologias asociadas con hmgb1. |
| US20060094753A1 (en) * | 2004-10-29 | 2006-05-04 | Alcon, Inc. | Use of inhibitors of Jun N-terminal kinases for the treatment of glaucomatous retinopathy and ocular diseases |
| US7803824B2 (en) * | 2004-10-29 | 2010-09-28 | Alcon, Inc. | Use of inhibitors of Jun N-terminal kinases to treat glaucoma |
| JP2008520730A (ja) * | 2004-11-23 | 2008-06-19 | セルジーン・コーポレーション | 中枢神経系傷害の治療用jnk阻害剤 |
| US20060223807A1 (en) | 2005-03-29 | 2006-10-05 | University Of Massachusetts Medical School, A Massachusetts Corporation | Therapeutic methods for type I diabetes |
| KR20080044836A (ko) | 2005-07-15 | 2008-05-21 | 라보라뚜와르 세로노 에스. 에이. | 자궁내막증 치료용 jnk 억제제 |
| BRPI0613042A2 (pt) | 2005-07-15 | 2010-12-14 | Serono Lab | inibidores de jnk para o tratamento de endometriose |
| GB0516156D0 (en) | 2005-08-05 | 2005-09-14 | Eisai London Res Lab Ltd | JNK inhibitors |
| US9598669B2 (en) | 2005-12-29 | 2017-03-21 | Anthrogenesis Corporation | Composition for collecting placental stem cells and methods of using the composition |
| KR102484810B1 (ko) | 2016-05-25 | 2023-01-05 | (주)아모레퍼시픽 | 피부 미백용 조성물 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH538528A (de) * | 1968-11-07 | 1973-06-30 | Hoechst Ag | Verfahren zur Herstellung von faserreaktiven Farbstoffen |
| DE2200127A1 (de) * | 1972-01-03 | 1973-07-12 | Basf Ag | Verfahren zur herstellung von dichlor1,1'-dianthrachinonylen und deren derivaten |
| DE2558813C2 (de) * | 1975-12-27 | 1984-10-31 | Hoechst Ag, 6230 Frankfurt | Lichtempfindliches Gemisch mit synergistischem Initiatorsystem |
| US4198518A (en) * | 1977-09-02 | 1980-04-15 | Ciba-Geigy Corporation | Process for the production of 3-substituted pyrazolanthrones |
-
2000
- 2000-08-19 KR KR1020087006016A patent/KR20080028516A/ko not_active Withdrawn
- 2000-08-19 KR KR1020027002168A patent/KR100835700B1/ko not_active Expired - Fee Related
- 2000-08-19 HK HK02109283.5A patent/HK1053107A1/zh unknown
- 2000-08-19 JP JP2001517507A patent/JP2003532626A/ja active Pending
- 2000-08-19 WO PCT/US2000/022727 patent/WO2001012609A1/en not_active Ceased
- 2000-08-19 EP EP00955709A patent/EP1218347A1/en not_active Withdrawn
- 2000-08-19 NZ NZ517578A patent/NZ517578A/en unknown
- 2000-08-19 AU AU67863/00A patent/AU780306B2/en not_active Ceased
- 2000-08-19 CA CA002383268A patent/CA2383268A1/en not_active Abandoned
- 2000-08-19 CN CNB008143870A patent/CN1304375C/zh not_active Expired - Fee Related
-
2002
- 2002-02-15 ZA ZA200201312A patent/ZA200201312B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2401269C2 (ru) | Производные пирролотриазина, применимые для лечения гиперпролиферативных нарушений и заболеваний, связанных с ангиогенезом | |
| RU98123097A (ru) | Карбоксамиды бензофурана и их терапевтическое применение | |
| RU2409562C2 (ru) | Новые производные 2-азетидинона в качестве ингибиторов всасывания холестерина для лечения гиперлипидемических состояний | |
| CA2595182A1 (en) | Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith | |
| JP2008526989A5 (cg-RX-API-DMAC7.html) | ||
| JP2012532112A5 (cg-RX-API-DMAC7.html) | ||
| JP2002534519A5 (cg-RX-API-DMAC7.html) | ||
| JP2020530848A5 (cg-RX-API-DMAC7.html) | ||
| JP2012524084A5 (cg-RX-API-DMAC7.html) | ||
| RU2018120242A (ru) | Хинолиновые соединения, способы их получения и их применения в качестве лекарственного средства, ингибирующего транспортер уратов | |
| JP2006524706A5 (cg-RX-API-DMAC7.html) | ||
| JP2008509987A5 (cg-RX-API-DMAC7.html) | ||
| JP2019527724A5 (cg-RX-API-DMAC7.html) | ||
| JP2024519993A5 (cg-RX-API-DMAC7.html) | ||
| JP2024540318A5 (cg-RX-API-DMAC7.html) | ||
| JP2003503505A5 (cg-RX-API-DMAC7.html) | ||
| JP2006519868A5 (cg-RX-API-DMAC7.html) | ||
| RU2016125459A (ru) | Способ получения хиральных 2-арилморфолинов | |
| JP2014530831A5 (cg-RX-API-DMAC7.html) | ||
| JP2005505583A5 (cg-RX-API-DMAC7.html) | ||
| DE2415402A1 (de) | Cephalosporansaeurederivate, verfahren zu ihrer herstellung und ihre verwendung in pharmazeutischen zubereitungen | |
| JP2002512236A5 (cg-RX-API-DMAC7.html) | ||
| CA2626402A1 (en) | Potassium channel inhibitors | |
| JP2004531527A5 (cg-RX-API-DMAC7.html) | ||
| JP2002510689A5 (cg-RX-API-DMAC7.html) |